Denali Advisors LLC Shattuck Labs, Inc. Transaction History

Denali Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 21, 2023	SELL	$2.5 - $4.72 $9,500 - $17,936	-3,800 Reduced 29.01%	9,300 $27,000
Q2 2022 Jul 18, 2022	BUY	$2.7 - $4.59 $8,370 - $14,229	3,100 Added 31.0%	13,100 $53,000
Q1 2022 Apr 19, 2022	BUY	$4.22 - $8.89 $16,458 - $34,671	3,900 Added 63.93%	10,000 $42,000
Q4 2021 Jan 21, 2022	BUY	$8.36 - $21.08 $50,996 - $128,587	6,100 New	6,100 $52,000

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $46.6M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Denali Advisors LLC with notifications on news.